The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Abstract
A number of metalloproteins are important medicinal targets for conditions ranging from pathogenic infections to cancer. Many but not all of these metalloproteins contain a zinc(II) ion in the protein active site. Small‐molecule inhibitors of these metalloproteins are designed to bind directly to the active site metal ions. In this review several metalloproteins of interest are discussed, including matrix metalloproteinases (MMPs), histone deacetylases (HDACs), anthrax lethal factor (LF), and others. Different strategies that have been employed to design effective inhibitors against these proteins are described, with an effort to highlight the strengths and drawbacks of each approach. An emphasis is placed on examining the bioinorganic chemistry of these metal active sites and how a better understanding of the coordination chemistry in these systems may lead to improved inhibitors. It is hoped that this review will help inspire medicinal, biological, and inorganic chemists to tackle this important problem by considering all aspects of metalloprotein inhibitor design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In most cases, a drug molecule establishes coordination bonds with the zinc ion10 present in the protein”
From AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins (2014) · cites this paper as [10]
Citations
Cites
Miller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Research works printed but not linked: 12
- Rybacki J. J., 2005, The essential guide to prescription drugs
- Stetler‐Stevenson W. G., 1996, Am. J. Pathol., 148, 1345
- Montgomery A. M., 1994, Cancer Res., 54, 5467
- Reich R., 1988, Cancer Res., 48, 3307
- Jong G. P., 2006, Chin. J. Physiol., 49, 104
- 10.1172/JCI22304 · doi:10.1172/jci22304 · Paper page
- Cataldo D. D., 2003, Cell. Mol. Biol., 49, 875
- Matter H., 2004, Curr. Opin. Drug Discovery Dev., 7, 513
- Parkkila S., 2000, The carbonic anhydrases: new horizons
- Liao S. Y., 1994, Am. J. Pathol., 145, 598
- Lewis C., 2002, FDA Consum., 36, 11
- 10.1172/JCI20195 · doi:10.1172/jci20195 · Paper page
Cited by
Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 984
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins
Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500209e · Cited by 318
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Kónya, D., Kupai, K., Kovács, L., & Ferdinandy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 178
“As a viable solution, a combined approach was developed([20]) that carries out the fragment screening by ESI-MS first and then runs the NMR of the hits to identify the mode of action and major interactions.”
Metadata
- Authors
- Jacobsen, F. E., Lewis, J. A., & Cohen, S. M.
- Affiliations
- University of California San Diego (US)
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2007-01-30
- Volume
- 2
- Issue
- 2
- Pages
- 152-171
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W2102128466
- Cited by
- 132
- References
- 175
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 7 · 2013: 8 · 2012: 15
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- small molecule inhibitors, matrix metalloproteinases, histone deacetylase, anthrax lethal factor, bioinorganic chemistry, coordination chemistry
- MeSH terms
- Animals, Binding Sites, Catalysis, Cells, Cultured, Fibroblasts, Humans, Metalloproteins, Protease Inhibitors, Protein Conformation, Spectrum Analysis, Structure-Activity Relationship, Zinc, Drug Design, Inhibitory Concentration 50, Matrix Metalloproteinases, Myoblasts, Cardiac, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Design of Inhibitors for Medicinally Relevant Metalloproteins. https://app.cochat.ai/papers/10.1002/cmdc.200600204
- The paper
- Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007). The Design of Inhibitors for Medicinally Relevant Metalloproteins. ChemMedChem. https://doi.org/10.1002/cmdc.200600204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.